Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BELgian ANtiCoagulation Survey for Elderly Patients With NVAF

NCT04722679 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04722679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04722679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BELgian ANtiCoagulation Survey for Elderly Patients With NVAF
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 11, 2021
Completion date
January 3, 2022
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation